Concord Biotech IPO Sees Strong Day One Subscription Of 58% With NII Segment Fully Subscribed
Rare Enterprises-backed Concord Biotech's IPO witnessed a robust subscription of 58% on the first day, with the NII segment fully ...
Tag: NII Segment
Popular News
-
Former Swiss Air Force Officer Pascal Najadi announces theimminent surfacing of the covert US led Defense WarOperation #STORM in Public Address at the Tomb of Napoleon Bonaparte in Paris in January 2024.
-
World Startup Convention: A Massive Scam Disappoints Thousands Of Participants
-
Delhi University Announces No Entrance Exams For Admissions
-
Top 20 Influential Personalities To Look Out For In 2024: India’s Diverse Icons
-
Unveiling The Ayurveda Vs. Allopathy Debate: Shree Karauli Shankar Supports Baba Ramdev’s Cause
© 2025 Hindustan Herald | Be Debonair Foundation